The US Protein Hydrolysis Enzymes Market is poised for significant growth, driven by the rising demand in food processing, pharmaceuticals, and biotechnology. Major players are focusing on expanding their product portfolios and enhancing technological advancements to cater to diverse end-use industries. The market was valued at USD 890 million in 2025 and is expected to reach USD 1,940 million by 2035, growing at a CAGR of 7.8% from 2024 to 2035.
The economic impact of tariffs on "US Protein Hydrolysis Enzymes Market".
Market Growth Drivers
Rising demand for protein hydrolysates in food and beverage applications is a major growth driver. As consumers seek nutritious and easily digestible products, the utilization of enzymes such as proteases to break down proteins in food processing has surged. This trend is particularly prominent among sports nutrition and infant formula manufacturers. Companies such as Novozymes have invested heavily in R&D to improve enzyme efficacy and expand their food-grade enzyme product lines, further fueling the market.
Expanding biopharmaceutical production has boosted the requirement for advanced protein hydrolysis enzymes in drug formulation and bio-processing. With increased investment in biologics, enzymes facilitate more efficient protein breakdown for therapeutic applications, improving drug absorption and effectiveness. DuPont, for example, launched new enzyme blends aimed at protein hydrolysis for bio-pharma customers in late 2023, catering to specialized requirements in therapeutic protein production.
Market Trends
The adoption of green and sustainable enzyme manufacturing processes is a prominent trend. Companies, including BASF and DSM, are shifting towards bio-based fermentation methods to reduce environmental impact and ensure regulatory compliance. This shift is not only reducing the carbon footprint but also meeting the growing consumer demand for cleaner and environmentally friendly food and pharma inputs.
Customization and formulation-specific enzymes are gaining popularity. Rather than offering one-size-fits-all products, market leaders like Kerry Inc. are developing application-specific enzymes tailored for target substrates and desired hydrolysate profiles. This customization enhances the efficiency of the protein hydrolysis process for various industries, especially in niche segments such as medical nutrition and pet food.
Market Opportunities
Expansion opportunities exist in the plant-based protein segment, as consumers and manufacturers pivot towards sustainable protein sources. Enzyme companies can capitalize by offering specialized hydrolysis enzymes suitable for soy, pea, and other plant proteins. Companies like Amano Enzyme are actively developing solutions for this growing market.
Industry partnerships for end-to-end enzyme supply in biopharmaceutical production are emerging as a lucrative avenue. Collaboration between enzyme manufacturers and pharmaceutical companies can streamline supply chains and improve consistency in therapeutic protein manufacturing.
US Protein Hydrolysis Enzymes Market Revenue (USD Million), 2020-2035
The chart demonstrates a consistent upward trend in market revenue from 2020 to 2035. Starting at USD 560 million in 2020, the market revenue grows steadily due to increased demand from diverse sectors, technological advancements, and expansion into new application areas. By 2025, revenue is recorded at USD 890 million and is projected to reach USD 1,940 million by 2035, reflecting compounded annual growth. The momentum is especially pronounced after 2025, driven by innovation in enzyme formulations and expansion into biopharmaceutical applications.
US Protein Hydrolysis Enzymes Market Share by Region (%) - 2025
In 2025, the Midwest region holds the largest market share in the US Protein Hydrolysis Enzymes Market due to its concentration of food processing plants and biopharmaceutical facilities. The West and South regions also represent substantial portions of the market, attributed to thriving biotechnology sectors and rising health-conscious consumer bases. The Northeast captures a moderate share, while other regions collectively contribute a smaller percentage. The regional distribution signifies both established and emerging markets for enzyme applications across the country.
Recent Developments in the US Protein Hydrolysis Enzymes Market
In March 2024, Novozymes announced the launch of Protazyme™ Ultra, a next-generation enzyme solution tailored for plant-derived protein hydrolysis, enhancing solubility and nutritional quality for use in sports nutrition products. This development underscores Novozymes’ commitment to innovation in clean-label and high-performance enzyme solutions.
In May 2024, DSM-Firmenich completed the expansion of its US enzyme production facility in Iowa, boosting overall capacity for protein hydrolysis enzymes destined for both food and pharmaceutical markets. The expansion is expected to accelerate supply and reduce lead times, supporting the growing demand for specialized protease blends.
In April 2024, DuPont Nutrition & Biosciences formed a strategic partnership with a major North American biopharma company to jointly develop customized enzyme solutions for therapeutic protein production. This alliance aims to deliver optimized enzyme formulations tailored to biopharmaceutical processes, expediting drug development pipelines and enhancing manufacturing consistency.
By Type (Proteases, Exopeptidases, Endopeptidases, Microbial Protein Hydrolysis Enzymes, Plant-derived Protein Hydrolysis Enzymes, Animal-derived Protein Hydrolysis Enzymes), By Application (Food & Beverage, Pharmaceuticals, Animal Feed, Detergents, Biotechnology, Other Applications), By Distribution Channels (Direct Sales, Distributors, Online Retail, Specialty Stores, Others), By Technology (Fermentation, Extraction, Recombinant DNA Technology, Enzyme Engineering, Others), By Organization Size (Small, Medium, Large)
Press Releases